Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.77% | 34.53% | -17.51% | -12.19% | -46.00% |
| Total Depreciation and Amortization | 75.52% | 42.27% | -19.00% | -16.74% | -39.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.46% | -104.02% | 8.63% | -8.70% | 552.59% |
| Change in Net Operating Assets | 10.47% | 4.48% | 2.27% | -16.27% | 31.25% |
| Cash from Operations | -11.95% | -8.86% | -33.29% | -47.78% | -21.78% |
| Capital Expenditure | -- | -25.00% | 34.38% | 34.38% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -91.48% | -- | -- | -- |
| Cash from Investing | -- | -91.91% | 34.38% | 34.38% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.40% | 91.33% | 66.33% | 41.33% | 16.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,816.33% | 1,501.83% | 330.00% | 41.33% | 16.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.04% | -969.07% | -17.47% | -43.31% | -19.21% |